Home  >> Transactions>> Abbott has sold certain pharmaceutical assets to Inventiva

Abbott has sold certain pharmaceutical assets to Inventiva

Abbott Laboratories (NYSE: ABT) has sold the assets of Fournier R&D laboratories, located in Daix, France, to Inventiva, a company created as part of a management buyout. The assets include 12 000 m² of laboratories and equipment and a 230,000 molecule library, and will address four therapeutic targets: Parkinson’s disease, oncology, autoimmune diseases and fibrosis. In addition Abbott has signed a five-year partnership with Inventiva that will finance a large part of the operating costs. EC Mergers & Acquisitions acted as exclusive advisor to Abbott on this transaction.


Steel Partners has acquired PST Group      Learn More >>
Galileo TP has been sold to Burke Porter Group      Learn More >>
Entegris Has Acquired Flex Concepts, Inc.      Learn More >>
Hänsel Group has sold a majority stake to Possehl      Learn More >>
Entegris has acquired SAES Pure Gas Business from SAES Group      Learn More >>
Ldetek has been sold to Battery Ventures’ Process Sensing Technologies Group      Learn More >>
Axel Johnson International acquires MAK Aandrijvingen      Learn More >>
SPX has acquired CUES, Inc.      Learn More >>
Dickson Data has been sold to May River Capital      Learn More >>
SPX has acquired Schonstedt Instrument Company      Learn More >>
Quantachrome Instruments has been sold to Anton Paar      Learn More >>
PIP Global has partnered with Audax Private Equity      Learn More >>